What Bioamiens does

Bioamiens is a private, independent medical biology laboratory founded in 1966 and headquartered in Amiens, France. It operates five physical sites across the Amiens metropolitan area (Albert 1er, Vallée des Vignes, Montières, Saint Acheul, and Route de Rouen) serving general public patients, pediatric patients, and healthcare professionals. The laboratory's service portfolio spans routine blood tests and microbiological samples, COVID-19 PCR testing, prenatal trisomy 21 screening, hyperglycemia provocation testing (OGTT/O'Sullivan), and specialized pediatric phlebotomy for children under six. Its Vallée des Vignes site is authorized for medically assisted reproduction (PMA), including insemination, IVF, ICSI, and embryo cryopreservation, delivered in partnership with Centre Privé Picard d'Assistance Médicale à la Procréation.

The technology stack centers on standardized medical biology workflows augmented by digital patient-facing interfaces: a secure online results portal (MyKali) that delivers encrypted PDF results via email, Doctolib-based online appointment booking across all five sites, a dedicated result-access server for healthcare professionals, and integration with France's national shared health record (Mon Espace Santé / DMP). Operational quality is governed by ISO 15189 accreditation (n°8-4065) from COFRAC. Since 2021, Bioamiens has partnered with Enterprise GeodAIsics® (Grenoble) on AI-powered quality monitoring and result interpretation tools, with project completion targeted for 2025. The lab also maintains an internal anonymized biological data and sample collection (up to 20 years retention) usable for technique evaluation, staff training, and scientific research under patient consent.

The business model is a professional services / fee-for-service operation under France's third-party payer (tiers payant) system. Revenue is generated primarily through billing the French Sécurité sociale and mutual insurance for prescribed tests, with direct patient payment for non-prescribed examinations. Marketing is largely digital and referral-based: the company website, Doctolib appointments, online contact forms, and word-of-mouth referrals from healthcare professionals. Ownership is private and stable, with six named medical biologists (Drs. Bourdrel, Duverlie, Jean, Jutard, Maille, and Rosant Legendre); no external investors, funding rounds, or M&A are disclosed.

Name

Bioamiens

Legal name

Laboratoire d'analyses de biologie médicale Amiens Bioamiens

Website

https://bioamiens.com

Company type

Private

Founded year

1966

Operating status

Operating

Headcount range

51–100 employees

Short description

Bioamiens is a private, independent medical biology laboratory founded in 1966 in Amiens, France, operating five sites that deliver blood tests, microbiological analyses, COVID-19 testing, fertility treatments, and pediatric phlebotomy to the Amiens metropolitan area.

Ownership category

akta.pro rank

Product category

Medical Diagnostic Laboratory Services

NAICS

Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071), Services-Health Services (8000)

akta.pro primary industry

Genetic & Prenatal Testing Laboratories (HLAFAMAH)

akta.pro secondary industry

Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)

Keywords

• Medical biology laboratory
• Clinical diagnostics services
• Assisted reproduction services
• Blood testing services
• COVID-19 PCR testing

Headquarters

HQ city

Amiens

HQ country

France

HQ region

Europe

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Medical Biology Analysis Services: Laboratory performs medical biology analyses including blood tests, microbiological samples, genetic testing, and assisted reproduction services (PMA). Revenue generated through third-party payer billing (Sécurité sociale, mutuelles) and direct patient payment for non-prescribed tests.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Bioamiens is a local independent medical biology laboratory founded in 1966 operating across five sites in the Amiens metropolitan area, performing diagnostic analyses (blood tests, microbiological samples, urinalysis, stool analysis), COVID-19 PCR testing, specialized pediatric phlebotomy, and authorized assisted reproduction services (insemination, IVF, ICSI, embryo cryopreservation) along with trisomy 21 prenatal screening. Patients can walk in or book appointments via Doctolib and receive results securely through encrypted PDF emails or the MyKali online portal, with billing handled through French Sécurité sociale and mutuelles (third-party payer system).

Product overview

Bioamiens is a local independent medical biology laboratory founded in 1966, composed of 5 laboratory sites across the Amiens metropolitan area (Albert 1er, Vallée des Vignes, Montières, Saint Acheul, and Route de Rouen). The laboratory provides a comprehensive range of medical analysis services including standard blood tests, microbiological samples, and specialized diagnostics. Key specialized services include fertility treatments (assistance médicale à la procréation - AMP/IVF/ICSI), trisomy 21 screening, and pediatric sample collection. The company operates patient-facing digital services including an online results delivery portal (MyKali) for secure encrypted PDF results via email, and Doctolib-based online appointment booking. Bioamiens integrates with France's national health system (Mon Espace Santé/DMP) for results transmission, and collaborates with Enterprise GeodAIsics® for AI-powered quality improvement tools.

Differentiator

Problem solved

Functional benefit

Products and services

• Analyse de Biologie Médicale (Medical Biology Analysis) Core laboratory analysis services including blood tests, microbiological samples (genital, ENT, nails, hair), urinalysis, and stool analysis performed across all 5 Bioamiens sites in the Amiens metropolitan area for patients referred by physicians.
• Dépistage COVID-19 (COVID-19 PCR Testing) COVID-19 nasopharyngeal PCR testing services available at multiple Bioamiens laboratory sites including Vallée des Vignes, Albert 1er and Route de Rouen locations.
• Assistance Médicale à la Procréation (AMP/PMA) Authorized fertility treatment services including insemination, IVF (Fécondation In Vitro), ICSI (Intracytoplasmic Sperm Injection), and embryo cryopreservation, delivered at the Vallée des Vignes site in collaboration with Centre Privé Picard d'Assistance Médicale à la Procréation.
• Dépistage de la Trisomie 21 Prenatal genetic screening for trisomy 21 (Down syndrome) performed at the authorized Vallée des Vignes site, with specific result delivery protocols for genetic testing.
• Spermogramme et Préparations FIV Semen analysis (spermogramme) and preparations for insemination or IVF, including pre-IVF consultations with certified biologists, available by appointment at the Vallée des Vignes site.
• Hyperglycémies Provoquées (HGPO) Oral Glucose Tolerance Test (OGTT) and O'Sullivan test for diabetes screening, available at Vallée des Vignes and Albert 1er sites.
• Prélèvements Pédiatriques Pediatric blood draws and sample collection (urine collection bags) for infants and children; children under 6 years must be seen at the Vallée des Vignes site by appointment via Doctolib.

Named customers1 record

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability1 record

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• Enterprise GeodAIsics® (Grenoble)coreTechnology or Integration · 1 January 2021Partnership with Enterprise GeodAIsics® (Grenoble) for the development of innovative tools using artificial intelligence to improve the quality of biology results and assist in analysis and interpretation. The laboratory works with this partner to improve analytical surveillance systems and aid in result interpretation. Theoretical completion date: 2025. Used for internal purposes, quality assurance, analytical validation, and personalized medicine.
• Centre Privé Picard d'Assistance Médicale à la ProcréationcoreStrategic or Co-development PartnerCollaboration with the Centre Privé Picard d'Assistance Médicale à la Procréation for assisted reproduction services. The Vallée des Vignes laboratory, authorized for PMA (assisted medical reproduction) and Trisomy 21 screening, works with this center for patient referrals and joint reproductive health services.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Inovie: Major French medical biology lab network operating more than 500 sites nationwide. Directly comparable on business model (multi-site clinical lab, French reimbursement billing, general and specialty diagnostics) and poses the most direct competitive threat to Bioamiens in regional markets.
• Synlab France: French arm of pan-European medical diagnostics leader Synlab. Operates multiple laboratory sites across France offering routine and specialty diagnostics; directly comparable business model and represents a potential acquirer or competitor in regional French lab markets.
• Unilabs France: French operations of European diagnostics group Unilabs, with multiple lab sites offering clinical biology, genetics and reproductive medicine. Direct comparable on multi-site French lab model and specialty diagnostics including PMA-adjacent services.
• Cerballiance: One of France's largest medical biology laboratory networks with hundreds of sites across the country. Directly comparable to Bioamiens as a multi-site French clinical lab offering routine and specialty diagnostics, including fertility and prenatal services, with similar tiers payant billing model.
• Biogroup: Large French medical biology network formed from consolidation of regional labs including Labosud. Operates multi-site clinical labs across multiple French regions with similar service mix and reimbursement exposure — direct comparable to Bioamiens at a regional French lab level.

Broad incumbents

• Eurofins Biomnis: French reference laboratory within the Eurofins group, specializing in advanced and specialty clinical diagnostics including reproductive genetics and prenatal screening. Comparable to Bioamiens on specialty service overlap (PGT, trisomy 21) but operates at much broader geographic and test-menu scale.
• Cerba Healthcare: French specialty/reference laboratory network with deep specialty diagnostics portfolio. Comparable on lab services and French market presence, but operates at significantly larger scale and with broader specialty test menu than Bioamiens — represents an incumbent competitor in specialty services like genetics and reproductive medicine.

Others

• Doctolib: Leading French healthcare appointment booking platform already integrated with Bioamiens for online scheduling. Adjacent ecosystem partner rather than competitor — represents the digital infrastructure layer through which independent French labs acquire patients and is itself reshaping the competitive dynamics of the French clinical lab market.

Regional players

• Exalab: French regional medical biology laboratory network serving southwestern France with multi-site operations and similar routine/specialty test mix. Comparable to Bioamiens as a regional French clinical lab but operates in a non-overlapping geographic catchment.
• Laborizon Maine Anjou: Regional French medical biology laboratory network operating primarily in western France. Comparable multi-site regional lab model but serves a different geography, illustrating the type of regional consolidation target or peer that Bioamiens could expand into or compete against.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/laboratoirebioamiens
• LinkedInlinkedin.com/company/bioamiens

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bioamiens